mid cap stock june 1 2017 to august 18 2017

Skyline (SKY) had the highest return between June 1, 2017 and August 18, 2017 by a mid-cap US stock, returning 106.8%.

ASSETDATE% RETURN
Skyline (SKY)
6/1/2017 - 8/18/2017
106.81%
Leonardo DRS, Inc Common Stock (DRS)
6/1/2017 - 8/18/2017
83.56%
Option Care Health (OPCH)
6/1/2017 - 8/18/2017
70.72%
Amicus Therapeutics (FOLD)
6/1/2017 - 8/18/2017
55.79%
Hudbay Minerals (HBM)
6/1/2017 - 8/18/2017
54.9%
Autohome (ATHM)
6/1/2017 - 8/18/2017
51.73%
TAL Education (TAL)
6/1/2017 - 8/18/2017
50.85%
Constellium (CSTM)
6/1/2017 - 8/18/2017
50.75%
Travere Therapeutics (TVTX)
6/1/2017 - 8/18/2017
49.69%
Immunitybio (IBRX)
6/1/2017 - 8/18/2017
49.04%
Arrowhead Pharmaceuticals (ARWR)
6/1/2017 - 8/18/2017
44.22%
Appfolio (APPF)
6/1/2017 - 8/18/2017
43.96%
Warrior Met Coal (HCC)
6/1/2017 - 8/18/2017
42.21%
Avis Budget (CAR)
6/1/2017 - 8/18/2017
40.3%
PTC Therapeutics (PTCT)
6/1/2017 - 8/18/2017
39.22%
Star Bulk Carriers (SBLK)
6/1/2017 - 8/18/2017
36.45%
Sunrun (RUN)
6/1/2017 - 8/18/2017
35.64%
Crispr Therapeutics (CRSP)
6/1/2017 - 8/18/2017
33.28%
Burford Capital (BUR)
6/1/2017 - 8/18/2017
33.19%
Alarm (ALRM)
6/1/2017 - 8/18/2017
30.64%
IAMGold (IAG)
6/1/2017 - 8/18/2017
30.43%
Catalyst Pharmaceuticals (CPRX)
6/1/2017 - 8/18/2017
30.05%
Axsome Therapeutics (AXSM)
6/1/2017 - 8/18/2017
29.87%
Crocs (CROX)
6/1/2017 - 8/18/2017
29.07%
iRhythm Technologies (IRTC)
6/1/2017 - 8/18/2017
28.91%
Mid-cap stocks are treated as having a market cap between $2B and $10B.